Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism
1 other identifier
interventional
80
1 country
1
Brief Summary
Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=20 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Control and NMES group will self administer stimulation at home. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 19, 2024
CompletedFirst Submitted
Initial submission to the registry
December 3, 2024
CompletedFirst Posted
Study publicly available on registry
December 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2031
December 9, 2024
December 1, 2024
5 years
December 3, 2024
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glycemic Control
Insulin Sensitivity will be measured through repeated blood sampling during an Oral Glucose Tolerance Test and Continuous Glucose Monitoring
8 weeks
Secondary Outcomes (2)
Respiratory Exchange Ratio
8 Weeks
Amount of lean mass
8 weeks
Study Arms (4)
Control
PLACEBO COMPARATORParticipants will receive stimulation only up to sensory level.
NMES
EXPERIMENTALParticipants will receive stimulation up to maximum tolerable level.
Resistance Training
PLACEBO COMPARATORParticipants will receive exercise training with stimulation up to sensory level.
Resistance Training + NMES
EXPERIMENTALParticipants will receive exercise training with stimulation up to maximum tolerable intensity.
Interventions
Group will receive Electrical Stimulation up to sensory level
Group will receive Electrical Stimulation up to maximum tolerable level
Group will receive exercise training.
Eligibility Criteria
You may qualify if:
- Overweight/Obese (BMI ≥25)
- Sedentary Lifestyle: Physical Activity Level\<1.4
- Less than 150min/week of structured Exercise
You may not qualify if:
- Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications
- Excessive alcohol, drug abuse, smoking
- Pregnant Women
- Unwilling to adhere to the study Intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas at El Paso
El Paso, Texas, 79968, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 3, 2024
First Posted
December 9, 2024
Study Start
August 19, 2024
Primary Completion (Estimated)
September 1, 2029
Study Completion (Estimated)
September 1, 2031
Last Updated
December 9, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share